Histopathologic Characteristics, Recurrence Patterns, and Survival of 129 Patients With Desmoplastic Melanoma
暂无分享,去创建一个
D. Tyler | H. Seigler | M. Selim | P. Mosca | K. Posther | W. Stanley | Jeffrey L. Johnson | M. Selim | Jeffrey L. Johnson
[1] M. Lens,et al. Desmoplastic malignant melanoma: a systematic review , 2005, The British journal of dermatology.
[2] J. Thomas,et al. Excision margins in high-risk malignant melanoma. , 2004, The New England journal of medicine.
[3] Jennifer L. Schwartz,et al. Desmoplastic and neurotropic melanoma , 2004, Cancer.
[4] Jean Kanitakis,et al. Vascular endothelial growth factor‐C expression correlates with lymph node localization of human melanoma metastases , 2003, Cancer.
[5] A. Baldi,et al. cDNA array technology in melanoma: An overview , 2003, Journal of cellular physiology.
[6] S. Nathanson,et al. Insights into the mechanisms of lymph node metastasis , 2003, Cancer.
[7] Michael Detmar,et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. , 2003, The American journal of pathology.
[8] D. Elder,et al. Desmoplastic neurotropic melanoma of the head and neck: The role of radiation therapy , 2002, Head & neck.
[9] R. Barr,et al. S100-Positive Spindle Cells in Scars: A Diagnostic Pitfall in the Re-Excision of Desmoplastic Melanoma , 2002, The American Journal of dermatopathology.
[10] A. Ormsby,et al. A light microscopic and immunohistochemical evaluation of scars , 2002, Journal of cutaneous pathology.
[11] U. Bite,et al. The clinical behavior of desmoplastic melanoma. , 2001, American journal of surgery.
[12] R. Bentley,et al. CD34 expression in desmoplastic melanoma , 2001, Journal of cutaneous pathology.
[13] A. Folpe,et al. Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. , 2001, American journal of clinical pathology.
[14] Martin F. Mihm,et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] N Cascinelli,et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] S. N. Agoff,et al. The p75 Neurotrophin Receptor, Relative to Other Schwann Cell and Melanoma Markers, Is Abundantly Expressed in Spindled Melanomas , 2001, The American Journal of dermatopathology.
[17] M. Kashani-Sabet,et al. Evaluation of sentinel lymph node status in spindle cell melanomas. , 2001, Journal of the American Academy of Dermatology.
[18] P. Allen,et al. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma , 2001, Histopathology.
[19] Martin F. Mihm,et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma , 2000, Cancer.
[20] J. Tschen,et al. Comparison of S-100 versus hematoxylin and eosin staining for evaluating dermal invasion and peripheral margins by desmoplastic malignant melanoma. , 2000, The American Journal of dermatopathology.
[21] C. Shea,et al. Recent developments in the pathology of melanocytic neoplasia. , 1999, Dermatologic clinics.
[22] D. Silvers,et al. Prenatal exposure to metronidazole and risk of childhood cancer , 1999, Cancer.
[23] C. O'brien,et al. Desmoplastic and desmoplastic neurotropic melanoma , 1998, Cancer.
[24] C. Cockerell,et al. Histologic differentiation of desmoplastic melanoma from cicatrices. , 1998, The American Journal of dermatopathology.
[25] B. Zelger,et al. Malignant Melanomas Simulating Various Types of Soft Tissue Tumors , 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[26] A. Sober,et al. Desmoplastic neurotropic melanoma. , 1997, Seminars in cutaneous medicine and surgery.
[27] U. Weidle,et al. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination. , 1997, The American journal of pathology.
[28] T. Longacre,et al. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. , 1996, The American journal of surgical pathology.
[29] M. Bothwell,et al. Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma. , 1996, Journal of the American Academy of Dermatology.
[30] M. Yaar,et al. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma , 1996, Journal of cutaneous pathology.
[31] D. Elder,et al. Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma , 1995, Cancer.
[32] K. J. Smith,et al. Desmoplastic malignant melanoma. , 1995, Journal of the American Academy of Dermatology.
[33] A. Sober,et al. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases , 1995, Cancer.
[34] M. Mihm,et al. Desmoplastic melanoma: clinicopathologic aspects of six cases. , 1992, Dermatology.
[35] J. H. Little,et al. Desmoplastic melanoma: Patterns of recurrence , 1992, World journal of surgery.
[36] S. Jain,et al. Desmoplastic Malignant Melanoma and Its Variants: A Study of 45 Cases , 1989, The American journal of surgical pathology.
[37] R. Reed,et al. Neurotropic melanoma: A variant of desmoplastic melanoma , 1979, The American journal of surgical pathology.
[38] R. Lattes,et al. Desmoplastic malignant melanoma (A rare variant of spindle cell melanoma) , 1972, Cancer.
[39] C. Qin. Morphological and immunophenotypic variations in malignant melanoma , 2004 .
[40] L. Akslen,et al. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] D. Coit,et al. Sentinel Lymph Node Biopsy for Patients With Cutaneous Desmoplastic Melanoma , 2003, Annals of Surgical Oncology.
[42] R. Lattes,et al. Desmoplastic malignant melanoma (A rare variant of spindle cell melanoma) , 1971 .